Corneal Cross-Linking-Induced Stromal Demarcation Line
@article{Seiler2006CornealCS,
title={Corneal Cross-Linking-Induced Stromal Demarcation Line},
author={Theo G. Seiler and Farhad Hafezi},
journal={Cornea},
year={2006},
volume={25},
pages={1057-1059}
}Purpose: Corneal collagen cross-linking by UVA/riboflavin (X-linking) represents a new method for the treatment of progressive keratoconus and currently is under clinical study. To avoid UVA irradiation damage to the corneal endothelium, the parameters for X-linking are set in a way that effective treatment occurs only in the first 300 μm of the corneal stroma. Here, X-linking not only strengthens the biomechanical properties of the cornea but also induces keratocyte apoptosis. To date, the…
Topics from this paper
352 Citations
Corneal Collagen Cross-Linking
- MedicineMiddle East African journal of ophthalmology
- 2010
The major indication for the use of CXL is to inhibit the progression of corneal ectasias, such as keratoconus and pellucid marginal degeneration, and may also be effective in the treatment and prophylaxis of iatrogenic keratectasia, resulting from excessively aggressive photoablation.
Increased Reaction after Cross-linking in Keratoconus Melanoderm Patients
- MedicineOcular immunology and inflammation
- 2014
Increased stromal reaction observed in 4 eyes of 3 melanoderm patients who underwent CXL for evolutive keratoconus is described, indicating probably the efficiency of the procedure.
Corneal Collagen Cross-Linking for Keratoconus and Corneal Ectasia
- Medicine
- 2014
It is reasonable to consider all eyes with progressive keratoconus or corneal ectasia for cross-linking treatment; however, eyes with good visual acuity may be somewhat more susceptible to a loss of 1 Snellen line of acuity after CXL.
Corneal stromal demarcation line after collagen cross-linking in corneal ectatic diseases: a review of the literature
- MedicineClinical ophthalmology
- 2016
Evaluation of demarcation line (DL), a transition zone between the cross-linked anterior corneal stroma and the untreated posterior cornea, is considered a measurement of the depth of CXL treatment into the stroma, which indicates effectiveness of the CXL.
Corneal collagen cross-linking (CXL) in thin corneas
- MedicineEye and Vision
- 2015
The overall safety and efficacy of the modified CXL protocols are good, as most of them managed to halt the progression of keratectasia without postoperative complications, but controlled studies with long-term follow-up are required.
Reduced cross-linking demarcation line depth at the peripheral cornea after corneal collagen cross-linking.
- MedicineJournal of refractive surgery
- 2013
Both the CXL demarcation line depth and its proportion over the corneal thickness were greater at the central cornea than the peripheral cornea.
Epithelium-Off Corneal Cross-Linking
- Medicine, BiologyControversies in the Management of Keratoconus
- 2018
The chapter describes briefly standard “Dresden protocol” and also accelerated mode of CXL treatment, and the importance of medical history of the patient, evidence of the progression of keratoconus and possible complications after the procedure are turned to.
Collagen Cross Linking in Keratoconus: A Review
- Medicine
- 2017
The modifications in CXL halt the progression of keratectasia without postoperative complications and the evidence of safety and efficacy in the use of modified CXL protocols is still limited to few studies with few patients involved.
Marked remodelling of the anterior corneal surface following collagen cross-linking with riboflavin and UVA
- MedicineBritish Journal of Ophthalmology
- 2010
Three cases that did not display regression but rather displayed a massive remodelling with Kmax reduction of up to 9.5 dioptres (D), accompanied by formation of a deep stromal opacity and a distinct increase in best spectacle-corrected visual acuity (BSCVA) are reported.
Corneal collagen cross-linking following superficial keratectomy as treatment for corneal endothelial cell dystrophy in dogs: Preliminary clinical study.
- MedicineVeterinary ophthalmology
- 2018
Collagen cross-linking with SK has the potential to reduce the corneal thickness in CED cases; however, a lasting clinically significant improvement of corneAL transparency seems unlikely.
References
SHOWING 1-10 OF 16 REFERENCES
[Treatment of keratoconus by collagen cross linking].
- MedicineDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
- 2003
The results show that collagen cross linking might be a useful conservative treatment modality to stop the progression of keratoconus and the need for keratoplasty might be significantly reduced.
Keratocyte Apoptosis After Corneal Collagen Cross-linking Using Riboflavin/UVA Treatment
- MedicineCornea
- 2004
Riboflavin/UVA treatment leads to a dose-dependent keratocyte damage that can be expected in human corneas down to a depth of 300 &mgr;m using a surface UVA dose of 5.4 J/cm2.
Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus.
- MedicineAmerican journal of ophthalmology
- 2003
Induction of cross-links in corneal tissue.
- MedicineExperimental eye research
- 1998
The biomechanical behaviour of the cornea can be altered by glutaraldehyde, Karnovsky's solution, and with riboflavin and UV-irradiation which offers the potential of a conservative treatment of keratoconus.
[Increased rigidity of the cornea caused by intrastromal cross-linking].
- MedicineDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
- 1997
The biomechanical behaviour of the cornea can be altered by low-concentration glutaraldehyde, Karnovsky's solution, and by riboflavin and UV irradiation, which offers potential conservative treatment of keratoconus.
Parasurgical therapy for keratoconus by riboflavin–ultraviolet type A rays induced cross‐linking of corneal collagen: Preliminary refractive results in an Italian study
- MedicineJournal of cataract and refractive surgery
- 2006
Corneal Endothelial Cytotoxicity of Riboflavin/UVA Treatment in vitro
- Medicine, BiologyOphthalmic Research
- 2003
A cytotoxic effect of the combined riboflavin/UVA treatment on corneal endothelial cells is to be expected with aCorneal thickness of less than 400 µm, therefore, pachymetry should be routinely performed before rib oflavin or UVA treatment to exclude patients at risk.
Techniques for stiffening the cornea.
- MedicineJournal of refractive surgery
- 1999
Riboflavin and UV seems to be a promising technique to stabilize the cornea by artificial cross-linking and to determine a dose-response relation.
Stress‐strain measurements of human and porcine corneas after riboflavin–ultraviolet‐A‐induced cross‐linking
- MedicineJournal of cataract and refractive surgery
- 2003
[Studies on the stabilization of the cornea in rabbits].
- MedicineDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
- 2000
The cross-linking technique using riboflavin plus UV irradiation is suitable for at least temporarily stiffening the cornea in vivo and seems to be a promising method for conservative treatment of keratectasia.